Literature DB >> 23793845

Role of inflammasomes and their regulators in prostate cancer initiation, progression and metastasis.

Sudhakar Veeranki1.   

Abstract

Prostate cancer is one of the main cancers that affect men, especially older men. Though there has been considerable progress in understanding the progression of prostate cancer, the drivers of its development need to be studied more comprehensively. The emergence of resistant forms has also increased the clinical challenges involved in the treatment of prostate cancer. Recent evidence has suggested that inflammation might play an important role at various stages of cancer development. This review focuses on inflammasome research that is relevant to prostate cancer and indicates future avenues of study into its effective prevention and treatment through inflammasome regulation. With regard to prostate cancer, such research is still in its early stages. Further study is certainly necessary to gain a broader understanding of prostate cancer development and to create successful therapy solutions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23793845      PMCID: PMC6275599          DOI: 10.2478/s11658-013-0095-y

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN: 1425-8153            Impact factor:   5.787


  57 in total

1.  Immunomodulatory IL-18 binding protein is produced by prostate cancer cells and its levels in urine and serum correlate with tumor status.

Authors:  Kazutoshi Fujita; Charles M Ewing; William B Isaacs; Christian P Pavlovich
Journal:  Int J Cancer       Date:  2010-11-16       Impact factor: 7.396

2.  Chlamydial infection of monocytes stimulates IL-1beta secretion through activation of the NLRP3 inflammasome.

Authors:  Ali A Abdul-Sater; Najwane Saïd-Sadier; Eduardo V Padilla; David M Ojcius
Journal:  Microbes Infect       Date:  2010-04-29       Impact factor: 2.700

Review 3.  Inflammasomes in carcinogenesis and anticancer immune responses.

Authors:  Laurence Zitvogel; Oliver Kepp; Lorenzo Galluzzi; Guido Kroemer
Journal:  Nat Immunol       Date:  2012-03-18       Impact factor: 25.606

Review 4.  Cancer treatment and survivorship statistics, 2012.

Authors:  Rebecca Siegel; Carol DeSantis; Katherine Virgo; Kevin Stein; Angela Mariotto; Tenbroeck Smith; Dexter Cooper; Ted Gansler; Catherine Lerro; Stacey Fedewa; Chunchieh Lin; Corinne Leach; Rachel Spillers Cannady; Hyunsoon Cho; Steve Scoppa; Mark Hachey; Rebecca Kirch; Ahmedin Jemal; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2012-06-14       Impact factor: 508.702

Review 5.  Thirty years of research on infection and prostate cancer: no conclusive evidence for a link. A systematic review.

Authors:  Jan Hrbacek; Michael Urban; Eva Hamsikova; Ruth Tachezy; Jiri Heracek
Journal:  Urol Oncol       Date:  2012-03-28       Impact factor: 3.498

6.  Mechanism of inhibition of matrix metalloproteinase-9 induction by NO in vascular smooth muscle cells.

Authors:  M V Gurjar; J DeLeon; R V Sharma; R C Bhalla
Journal:  J Appl Physiol (1985)       Date:  2001-09

7.  The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses.

Authors:  Vijay A K Rathinam; Zhaozhao Jiang; Stephen N Waggoner; Shruti Sharma; Leah E Cole; Lisa Waggoner; Sivapriya Kailasan Vanaja; Brian G Monks; Sandhya Ganesan; Eicke Latz; Veit Hornung; Stefanie N Vogel; Eva Szomolanyi-Tsuda; Katherine A Fitzgerald
Journal:  Nat Immunol       Date:  2010-03-28       Impact factor: 25.606

8.  Inflammatory atrophy on prostate needle biopsies: is there topographic relationship to cancer?

Authors:  Athanase Billis; Leandro L L Freitas; Luis A Magna; Ubirajara Ferreira
Journal:  Int Braz J Urol       Date:  2007 May-Jun       Impact factor: 1.541

9.  Association of the innate immunity and inflammation pathway with advanced prostate cancer risk.

Authors:  Rémi Kazma; Joel A Mefford; Iona Cheng; Sarah J Plummer; Albert M Levin; Benjamin A Rybicki; Graham Casey; John S Witte
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

10.  Senescence-associated secretory phenotype favors the emergence of cancer stem-like cells.

Authors:  J Cahu; S Bustany; B Sola
Journal:  Cell Death Dis       Date:  2012-12-20       Impact factor: 8.469

View more
  15 in total

Review 1.  Inflammation and prostate cancer: friends or foe?

Authors:  Gianluigi Taverna; Elisa Pedretti; Giuseppe Di Caro; Elena Monica Borroni; Federica Marchesi; Fabio Grizzi
Journal:  Inflamm Res       Date:  2015-03-19       Impact factor: 4.575

2.  Dietary Inflammatory Index and Site-Specific Cancer Risk: A Systematic Review and Dose-Response  Meta-Analysis.

Authors:  Ahmad Jayedi; Alireza Emadi; Sakineh Shab-Bidar
Journal:  Adv Nutr       Date:  2018-07-01       Impact factor: 8.701

3.  Gene expression profiling of biological pathway alterations by radiation exposure.

Authors:  Kuei-Fang Lee; Julia Tzu-Ya Weng; Paul Wei-Che Hsu; Yu-Hsiang Chi; Ching-Kai Chen; Ingrid Y Liu; Yi-Cheng Chen; Lawrence Shih-Hsin Wu
Journal:  Biomed Res Int       Date:  2014-09-08       Impact factor: 3.411

4.  G protein-coupled receptor GPR160 is associated with apoptosis and cell cycle arrest of prostate cancer cells.

Authors:  Caihong Zhou; Xinchuan Dai; Yi Chen; Yanyan Shen; Saifei Lei; Ting Xiao; Tamas Bartfai; Jian Ding; Ming-Wei Wang
Journal:  Oncotarget       Date:  2016-03-15

Review 5.  Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review.

Authors:  Alessandro Sciarra; Alessandro Gentilucci; Stefano Salciccia; Federico Pierella; Flavio Del Bianco; Vincenzo Gentile; Ida Silvestri; Susanna Cattarino
Journal:  J Inflamm (Lond)       Date:  2016-11-25       Impact factor: 4.981

Review 6.  Inflammasomes in Inflammation-Induced Cancer.

Authors:  Chu Lin; Jun Zhang
Journal:  Front Immunol       Date:  2017-03-15       Impact factor: 7.561

Review 7.  Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer.

Authors:  Sonia Missiroli; Mariasole Perrone; Caterina Boncompagni; Chiara Borghi; Alberto Campagnaro; Francesco Marchetti; Gabriele Anania; Pantaleo Greco; Francesco Fiorica; Paolo Pinton; Carlotta Giorgi
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

8.  Natriuretic Peptides Regulate Prostate Cells Inflammatory Behavior: Potential Novel Anticancer Agents for Prostate Cancer.

Authors:  Letizia Mezzasoma; Vincenzo Nicola Talesa; Egidia Costanzi; Ilaria Bellezza
Journal:  Biomolecules       Date:  2021-05-25

9.  Expression of Caspase-1 in breast cancer tissues and its effects on cell proliferation, apoptosis and invasion.

Authors:  Yanxia Sun; Yingzhen Guo
Journal:  Oncol Lett       Date:  2018-03-05       Impact factor: 2.967

Review 10.  NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword.

Authors:  Shaima'a Hamarsheh; Robert Zeiser
Journal:  Front Immunol       Date:  2020-07-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.